Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-02-05 / Cancer Immunol Res 2014 May;2(5):404-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-02-05 / Cancer Immunol Res 2014 May;2(5):404-92014-02-05 00:00:002019-02-15 08:48:45Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):53-63https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):53-632014-02-01 00:00:002019-02-15 08:35:18Immunotherapy in lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-02-01 / Anticancer Res. 2014 Feb;34(2):565-74https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-02-01 / Anticancer Res. 2014 Feb;34(2):565-742014-02-01 00:00:002014-02-01 00:00:00Fighting fire with fire: the revival of thermotherapy for gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-45https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-452014-02-01 00:00:002014-02-01 00:00:00Immunotherapy prospects in the treatment of lung cancer and mesothelioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002014-01-03 / Cancer Immunol. Immunother. 2014 Apr;63(4):321-33https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2014-01-03 / Cancer Immunol. Immunother. 2014 Apr;63(4):321-332014-01-03 00:00:002019-02-15 08:39:42Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
DNA fragmentation and caspase-independent programmed cell death by modulated electrohyperthermia
Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response
Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
Immunotherapy in lung cancer
Fighting fire with fire: the revival of thermotherapy for gliomas
Immunotherapy prospects in the treatment of lung cancer and mesothelioma
Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection
Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
Diffuse intrinsic pontine glioma: time for therapeutic optimism
Tumor cell lysates as immunogenic sources for cancer vaccine design
Antigen trapping by dendritic cells for antitumor therapy
Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine
Immunotherapy and lung cancer: current developments and novel targeted therapies
Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function
Dendritic cell-based vaccines: clinical applications in breast cancer
Novel dendritic cell-based vaccination in late stage melanoma
Dendritic cell immunotherapy in uterine cancer